For many patients, the path to a crucial MRI scan is blocked by more than just cost. It is a journey to a hospital radiology suite, a wait for a scarce, multi-million-dollar machine, and an experience that can be loud, claustrophobic, and intimidating. Adialante, a Minneapolis-based startup founded by two University of Minnesota biomedical engineering PhDs, is betting that the hardware itself is the primary barrier. Their goal is to build a silent, compact MRI system that fits in a clinic room, not a hospital basement, and uses a fraction of the power and hardware of traditional scanners [Perplexity Sonar Pro, 2025].
The Technical Wedge
Adialante's core technical claim is a significant reduction in the physical and operational footprint of magnetic resonance imaging. The company says its design requires one-third less hardware, one-tenth the power, and occupies a space ten times smaller than a standard MRI, while matching diagnostic resolution through proprietary algorithms and modern computing [Perplexity Sonar Pro, 2025]. This is not a marginal improvement but an architectural shift aimed at a specific deployment model: placing scanners in outpatient clinics, community health centers, and mobile units. The initial product focus is on head-only and orthopedic applications, with a longer-term vision for a full-body system [University of Minnesota CTSI].
Funding a Hardware-Medtech Path
Building physical medical devices is a capital-intensive endeavor, especially one requiring eventual FDA clearance. Adialante's funding to date reflects a mix of academic validation and non-dilutive grant support, a common path for deep-tech university spinouts.
UMN Walleye Tank Grant (2023) | 0.01 | M USD
Seed Round (2023) | 1.5 | M USD
NSF SBIR Phase II Grant (2025) | 1.18 | M USD
The company's $1.5 million seed round, reported in 2023, was followed by a significant $1.18 million SBIR Phase II grant from the National Science Foundation in 2025 [Fogarty Innovation, 2025] [Great Lakes I-Corps, June 2025]. This grant funding is earmarked for the commercialization of the novel MRI technology. The founding team, CEO Efraín Torres and COO Parker Jenkins, are both recent or current UMN PhD students and have been advised by professor Michael Garwood, a noted MRI researcher [Perplexity Sonar Pro, 2025]. Torres was named the university's Student Entrepreneur of the Year in 2023 [University of Minnesota CSE BME, 2023].
The Patient Population and Standard of Care
Adialante is targeting a clear, unmet need in diagnostic imaging access. Today, the standard of care for an MRI typically involves a referral to a hospital or a dedicated imaging center. This creates significant friction:
- Geographic deserts. Rural and underserved urban communities often lack local access, forcing patients to travel long distances.
- Capacity bottlenecks. High-cost, fixed installations lead to scheduling delays that can impact diagnostic timelines, particularly for suspected cancers.
- Patient experience. Traditional scanners are loud and confining, which can be distressing and may require sedation for some patients. By aiming for a clinic-based model, Adialante is attempting to move the point of care closer to the patient, potentially enabling earlier screening and more routine monitoring for conditions like brain tumors or joint injuries. The promise of a silent scanner also addresses a real comfort and accessibility issue.
The Road to Commercialization
The company's stated next steps are clear: achieve FDA clearance and raise a Series A round to fund initial commercialization [Fogarty Innovation, 2025]. However, the path is lined with the formidable challenges inherent to novel medical hardware. The risks are not trivial, and the company will need to demonstrate several key milestones that go beyond technical prototypes.
- Regulatory validation. FDA 510(k) clearance or De Novo classification is a multi-year, data-intensive process. Peer-reviewed data on image quality and safety will be essential.
- Clinical utility. The system must prove it provides diagnostically equivalent images to current standards across a range of patient anatomies and conditions.
- Commercial adoption. Convincing clinic networks to adopt a new, unproven hardware platform requires overcoming entrenched procurement processes and reimbursement hurdles.
The competitive landscape includes established MRI giants like Siemens and GE, as well as other innovators aiming to reduce cost and size. Adialante's early differentiation rests on its specific combination of size, silence, and power efficiency claims. Its success will hinge on translating its academic prototypes into a reliable, manufacturable product that clinicians trust and payers will cover.
Sources
- [Fogarty Innovation, 2025] Transforming MRI Technology: Adialante's Vision for Accessible Healthcare | https://www.fogartyinnovation.org/transforming-mri-technology-adialantes-vision-for-accessible-healthcare/
- [Great Lakes I-Corps, June 2025] I-Corps Alumni, Adialante LLC, awarded $1.18 Million SBIR Phase II | https://greatlakesicorps.org/adialante-awarded-1-million-sbir-grant/
- [Perplexity Sonar Pro, 2025] Web-grounded research brief on Adialante
- [University of Minnesota CSE BME, 2023] Efraín Torres named Student Entrepreneur of the Year | https://cse.umn.edu/bme/news/efrain-torres-named-student-entrepreneur-year
- [University of Minnesota CTSI] Inventing a low-cost MRI to dramatically expand access | https://ctsi.umn.edu/news/inventing-low-cost-mri-dramatically-expand-access
- [University of Minnesota Research, December 2023] UMN Startup Adialante Wins Top Division and Grand Prize at Walleye Tank | https://research.umn.edu/news/umn-startup-adialante-wins-top-division-and-grand-prize-walleye-tank